Hepatocyte growth factor (HGF) markedly induced the spreading, dissociation and scattering of Madin ± Darby canine kidney epithelial cells (MDCK) and human stomach adenocarcinoma cells (TMK1). Scattering of MDCK and TMK1 cells was induced by 12-Otetradecanoyl-phorbol-13-acetate (PMA) and epidermal growth factor (EGF), respectively. In all these agentstimulated cells, rapid activation of Raf-1, MAP kinase/ ERK kinase (MEK), 41/43 kDa MAP kinases and p90 rsk was commonly observed. In contrast, PMA neither induced the scattering nor activation of all these kinases in TMK1 cells. Pretreatment of MDCK and TMK1 cells with 2-(2-amino-3-methoxyphenyl) choromone (AMPC), a speci®c inhibitor of MEK, selectively inhibited the HGF-, PMA-and EGF-stimulated activities of MEK, 41/43 kDa MAP kinases and p90 rsk in a dose dependent manner. AMPC-pretreatment, however, did not aect HGF-, PMA-or EGF-induced activation of Raf-1, nor HGF-induced activation of phosphatidylinositol 3-kinase in these cells. Importantly, HGF-, PMA-and EGFinduced scattering of MDCK and TMK1 cells was inhibited at doses of AMPC similar to those that gave comparable levels of inhibition of the activities of MEK, 41/43 kDa MAP kinases and p90 rsk . These results suggest that activation of the 41/43 kDa MAP kinase signaling pathway is required for the motility response of MDCK and TMK1 cells induced by agents such as HGF, PMA and EGF.
Introduction
Hepatocyte growth factor (HGF), also known as scatter factor (SF), is a mesenchymally derived heterodimeric protein consisting of a 60 kDa heavy chain and a 30 kDa light chain linked together by disul®de bonds. HGF is a multifunctional cytokine capable of inducing a wide variety of biological eects in normal and neoplastic cells. These include mitotic induction of hepatocytes as well as many types of epithelial and endothelial cells, dissociation of epithelial cell colonies into individual cells and stimulation of the motility (scattering) of epithelial cells, induction of epithelial morphogenesis, induction of angiogenesis, and promotion of the invasion of extracellular matrices. In vivo, HGF has been suggested to be involved in tissue regeneration, tumor invasion, and embryogenic processes, all of which generally require both cell motility and cell proliferation (Gherardi and Stoker, 1991; Nakamura, 1991; Birchmeier and Birchmeier, 1993; Rubin et al., 1993) .
HGF exerts its diverse eects through a high anity HGF receptor, which has been identi®ed as the c-met protooncogene product (Bottaro et al., 1991; Naldini et al., 1991) . The mature form of the c-Met receptor is a heterodimeric protein consisting of a 50 kDa extracellular a-subunit and a transmembrane 145 kDa bsubunit containing a catalytic tyrosine kinase domain (Park et al., 1987; Giordano et al., 1989) . Binding of HGF triggers autophosphorylation of the receptor on Tyr 1234 and Tyr 1235 of the b-subunit, which strongly upregulates its kinase activity. Two tyrosine residues located in the C-terminal tail of the b-subunit (Tyr   1349   and Tyr   1356 ) also become phosphorylated upon HGF binding. These phosphorylated tyrosine residues function as docking sites for Src homology 2 domaincontaining signal transducers such as phosphatidylinositol 3-kinase (PI3-kinase), phospholipase-Cg, Grb2 and Shc adaptor proteins, and pp60 c-src (Pawson, 1995; Comoglio and Boccaccio, 1996) . The activation of several other signaling molecules has been observed in HGF-stimulated cells; these include Ras (Graziani et al., 1993) , MAP kinases (ERKs) (Ponzetto et al., 1994) and focal adhesion kinase (Matsumoto et al., 1994) . Although a role for many of these signaling molecules has been established in cell mitogenesis, their role in the dissociation and scattering of epithelial cells remains largely unknown. In this respect, it is interesting that Ras function has recently been reported to be essential for mediating cell motility signal of HGF (Hartmann et al., 1994; Ridley et al., 1995) .
Ras is a 21 kDa GTP-binding protein which plays an essential role in diverse intracellular signaling processes (Lowy and Willumsen, 1993) . Ras functions as a molecular switch controlled by GTP/GDP cycling. Once in the active GTP-binding state, Ras interacts with eector proteins that then transmit signals from Ras to various intracellular signaling cascades. Although several targets of Ras such as Ras-GTPase activating protein and PI3-kinase have been reported, the best understood eector protein of Ras is the Raf-1, a serine/threonine kinase (Avruch et al., 1994) . Ras interacts directly with, and activates, Raf-1 by an unknown mechanism. Once activated, Raf-1 phosphorylates and activates a dual speci®city protein kinase known as MAP kinase/ERK kinase (MEK), which in turn phosphorylates and activates 41 kDa and 43 kDa MAP kinases (ERK2 and ERK1, respectively). Thus, Raf-1 exerts, at least partially, its eect through this protein kinase cascade (the MAP kinase cascade) (Nishida and Gotoh, 1993; Cobb and Goldsmith, 1995; Seger and Krebs, 1995) .
The 41 kDa and 43 kDa kinases phosphorylate and modulate the functions of many proteins with substantial regulatory functions. These include other protein kinases, transcription factors, cytoskeletal proteins and other enzymes (Davis, 1993) . Also, the regulation by these MAP kinases has been implicated in a wide array of physiological processes which include cell proliferation, neuronal cell dierentiation, activation of T-and B-cells, oocyte maturation, integrin-mediated cell adhesion, and secretion (Nishida and Gotoh, 1993; Cobb and Goldsmith, 1995; Seger and Krebs, 1995) . Accordingly, we have examined in this report whether or not activation of the 41 kDa and 43 kDa MAP kinases is involved in the signaling pathway that mediates HGFinduced cell scattering. For the analysis, we utilized a synthetic inhibitor of the MAP kinase cascade, 2-(2-amino-3-methoxyphenyl) chromone (AMPC), which is identical to the published compound PD98059 (Dudley et al., 1995) and which speci®cally inhibits MEK activity. Our results demonstrate that activation of the 41/43 kDa MAP kinase signaling pathway is required for HGF-induced cell scattering.
Results

HGF induces the scattering of MDCK and TMK1 cells
When Madin ± Darby canine kidney epithelial cells (MDCK) were seeded sparsely they proliferated as discrete colonies. This was also the case for human stomach adenocarcinoma cells (TMK1). Upon treatment with HGF, the MDCK and TMK1 cell colonies spread/dissociated within the ®rst 4 h, and then began to scatter *8 h after stimulation (Figure 1 ). The scattering of MDCK cells could also be induced by 12-Otetradecanoyl-phorbol-13-acetate (PMA) but not by a number of other growth factors such as epidermal growth factor (EGF) and insulin (not shown). TMK1 cells, however, could be induced to scatter by EGF but not by PMA. In contrast to the marked scattering of MDCK and TMK1 cells in response to HGF, PMA and EGF, these agents had only minor eects on the proliferation of those cells as determined by measuring the increase in cell number: i.e., HGF did not aect the proliferation of MDCK and TMK1 cells signi®cantly, EGF weakly stimulated the proliferation of MDCK cells but inhibited slightly the proliferation of TMK1 cells, and PMA did not measurably aect the proliferation of either MDCK or TMK1 cells (data not shown). To examine directly the role of activation of the MAP kinase signaling pathway in HGF-induced cell scattering, MDCK cells were pretreated for 30 min with various concentrations of 2-(2-amino-3-methoxyphenyl) chromone (AMPC), which is identical to the published compound PD98059 known to speci®cally inhibit MEK activity (Dudley et al., 1995) . The cells were then stimulated for 10 min with HGF, and MEK activity was determined. As shown in the inset of Figure 2A , pretreatment of the cells with AMPC inhibited the HGF-stimulated activity of MEK in a dose-dependent manner; this inhibition was partial, however, as 10 ± 20% of the maximal activity still remained in cells pretreated with AMPC even at concentrations over 50 mM. Incomplete inhibition of MEK activity has previously been observed in PC12 cells pretreated with PD98059 and stimulated with nerve growth factor . Next, we examined the eect of AMPC-pretreatment on the HGF-induced activation of 41/43 kDa MAP kinases. As shown in the inset of Figure 2B , pretreatment of MDCK cells with AMPC inhibited the HGF-induced tyrosine phosphorylation (data not shown) as well as activation of the 41/43 kDa MAP kinases in a dosedependent manner with complete inhibition being observed at 50 mM.
The inhibitory eect of AMPC on the HGF-, PMA-, and EGF-stimulated activities of MEK, 41/43 kDa MAP kinases and p90 rsk was analysed in MDCK and TMK1 cells by adding each of the above stimulatory rsk assay, and 10 mg of protein for MAP kinase assay) with respective antibodies followed by the kinase reaction as described under`Materials and methods'. (A and D) Radioactivity incorporated into GST-ERK2 K52R was quanti®ed with a Fujix Bioimaging analyser BAS 1500, and is expressed as the fold increase over that of the unstimulated control cell sample. (B and E) Radioactivity incorporated into MBP was determined, and is expressed as the fold increase over that of the unstimulated control cell sample (960+80 c.p.m.). (C and F) Radioactivity incorporated into the S6 peptide was determined, and is expressed as the fold increase over that of the unstimulated control cell sample (3980+340 c.p.m.). MDCK cells were preincubated with 0.1% Me 2 SO or various concentrations of AMPC for 30 min, followed by stimulation with 4 ng/ml of HGF for 10 min. (A, inset) MEK activity was determined, and is expressed as described above. (B, inset) 41/43 kDa MAP kinase activity was determined, and is expressed as described above. Radioactivity incorporated into MBP of the unstimulated control cell sample was 1700+120 c.p.m. Each value represents the mean+s. 
Pretreatment of MDCK and TMK1 cells with AMPC inhibits the HGF-induced cell scattering
To evaluate the speci®c role of the MAP kinase signaling pathway in HGF-, EGF-and PMA-induced cell scattering, MDCK and TMK1 cells were pretreated with various concentrations or 50 mM of AMPC for 30 min, followed by exposure to each stimulatory agent. As shown in Figure 4 , a concentration of 50 mM of AMPC completely inhibited the ability of MDCK and TMK1 cells to spread and scatter in response to HGF, PMA and EGF. Furthermore, the ability of AMPC to inhibit the motility response was dose-dependent and correlated well with its capacity to inhibit the MAP kinase signaling pathway. This was especially clear in the case of inhibition of 41/43 kDa MAP kinase activation which was induced by all these agents. Pretreatment of MDCK cells with other inhibitors such as wortmannin (a speci®c inhibitor of PI3-kinase, see Figure 5B ) (Ui et al., 1995) , rapamycin (a speci®c inhibitor of p70 S6K , which is a downstream target of PI3-kinase (Price et al., 1992) , or SB203580 (a speci®c inhibitor of p38 MAP kinase) (Cuenda et al., 1995) did not aect the HGF-induced scattering of the cells; neither did any of these agents signi®cantly inhibit the HGF-induced activation of 41/43 kDa MAP kinases (data not shown).
AMPC does not inhibit the HGF-stimulated activities of Raf-1 and PI3-kinase
In order to con®rm the speci®city of AMPC, we examined whether or not the activities of Raf-1 and PI3-kinase were aected by the pretreatment of cells with this compound, as activation of these kinases has been commonly observed in HGF-/EGF-treated cells (Comoglio and Boccaccio, 1996) . As shown in Figure  5A , HGF induced a rapid (peaked within 5 min) and transient activation of Raf-1 kinase in MDCK and TMK1 cells. The rapid activation of Raf-1 kinase was also observed in PMA-stimulated MDCK cells and in EGF-stimulated TMK1 cells, although the degree of Raf-1 kinase activation varied to some extent depending on the cell type and nature of the stimulant. Pretreatment of these cells with 50 mM AMPC did not inhibit the Raf-1 kinase activation induced by either HGF, EGF or PMA. Rather, compared to control cells, prior treatment of these cells with AMPC followed by treatment with any one of these stimulatory agents resulted in slightly higher activities of Raf-1 kinase. In this context, it has recently been reported that the MAP kinase signaling pathway is responsible for the feedback phosphorylation of SOS and subsequent dissociation of the Grb2-SOS complex, which thereby interrupts the ability of SOS to catalyze nucleotide exchange on Ras (Buday et al., 1995; Waters et al., 1995; Por®ri and McCormick, 1996) . Thus, the observed higher activities of Raf-1 kinase after stimulation with HGF, EGF and PMA in AMPC-pretreated cells may re¯ect the lower level of downregulation of Ras which would result from the speci®c inhibition of MEK activity by AMPC.
We next examined the activation of PI3-kinase in HGF-stimulated MDCK cells. As shown in Figure 5B , HGF apparently induced a rapid (peaked within 3 min) and transient activation of PI3-kinase in MDCK cells, which was completely abolished by pretreatment of the cells with wortmannin at concentrations over 0.1 mM. On the other hand, pretreatment rsk in TMK1 cells treated with HGF or EGF, and the inhibitory eect of AMPC-pretreatment on their activation. TMK1 cells were preincubated with 0.1% Me 2 SO or 50 mM AMPC for 30 min, followed by stimulation with 4 ng/ml of HGF, 10 ng/ml of EGF, or 30 ng/ml of PMA for 10 min. The MEK assay (A), 41/43 kDa MAP kinase assay (B), and p90 rsk assay (C) was performed by incubating cell lysates (30 mg of protein for MEK or p90 rsk assay, and 10 mg of protein for MAP kinase assay) with respective antibodies followed by the kinase reaction as described in the legend of of MDCK cells with 50 mM AMPC did not inhibit to any extent the PI3-kinase activation induced by HGF. The activation of PI3-kinase has been reported to be accomplished by the ligand-activated HGF receptor kinase-mediated tyrosine phosphorylation of its 85 kDa regulatory subunit (Graziani et al., 1991) , which was not aected by the pretreatment of cells with AMPC ( Figure 5B, right panel) . This result also indicated that AMPC did not inhibit the HGF-induced activation of its receptor, c-Met.
Discussion
HGF is a multifunctional cytokine that stimulates the proliferation, motility and tubulogenesis of epithelial cells. All these diverse biological eects of HGF are transduced by a high anity HGF receptor, c-Met. Recently, several downstream targets of the c-Met receptor have been identi®ed including PI3-kinase, phospholipase-Cg, pp60
c-src , Grb2 and Shc (Pawson, 1995; Comoglio and Boccaccio, 1996) . However, the nature of the downstream target of c-Met that mediate each of the many diverse biological signals of HGF remains currently unknown.
HGF markedly induced the spreading, dissociation and scattering of MDCK and TMK1 cells, with concomittant activation of Raf-1, MEK, 41/43 kDa MAP kinases and p90 rsk . Scattering of MDCK and TMK1 cells was also induced by treatment with PMA and EGF, respectively; in these cells activation of all the above mentioned signaling molecules was commonly observed. In contrast, PMA induced neither cell scattering nor activation of MEK and 41/43 kDa MAP kinases in TMK1 cells. The concomitant activation of the MAP kinase signaling pathway and cell scattering, when cells were stimulated with either HGF, PMA or EGF, suggests that this signaling pathway is involved in the ability of these agents to induce the motility response. However, speci®c inhibition of the MAP kinase cascade is required to clearly demonstrate a causal relationship between this signaling pathway and the induction of cell motility. In order to demonstrate a direct casual link between the MAP kinase cascade and cell scattering, a speci®c inhibitor of MEK, 2-(2-amino-3-methoxyphenyl) chromone (Dudley et al., 1995) was employed.
In MDCK and TMK1 cells, AMPC speci®cally inhibited the HGF-/EGF-/PMA-stimulated activities of MEK, 41/43 kDa MAP kinases and p90 rsk , but it did not aect these agent-induced activation of Raf-1 kinase or PI3-kinase. Importantly, this inhibition of the activation of 41/43 kDa MAP kinases correlated well with the ability of AMPC to inhibit HGF-/EGF-/ PMA-induced dissociation and scattering of MDCK and TMK1 cells. Furthermore, other well-characterized kinase inhibitors such as wortmannin, rapamycine and SB203580 did not inhibit HGF-induced scattering of MDCK cells; neither did any of these agents inhibit the HGF-induced activation of 41/43 kDa MAP kinases. All these observations point to a crucial role for the 41/ 43 kDa MAP kinases in the HGF-/EGF-/PMAinduced motility response of MDCK and TMK1 cells. It has previously been shown that the activity of Ras is essential to mediate the motility signal of HGF (Hartmann et al., 1994; Ridley et al., 1995). Our In this study, we have utilized a speci®c inhibitor of MEK in order to block the 41/43 kDa MAP kinase signaling pathway. As an alternative approach, we transiently expressed in MDCK cells a dominant interfering mutant of human MEK1, in which the serine residues 218 and 222 were replaced by nonphosphorylatable alanine residues, under the control of the cytomegalovirus promoter. In repeated experiments, we have not been able to observe complete inhibition of HGF-induced scattering. However, the HGF-induced motility response in these mutant MEK1-transfected MDCK cells showed a tendency to be delayed by several hours compared to that seen in cells transfected with the empty vector, which was also accompanied by a delayed onset and reduced levels of 41/43 kDa MAP kinase activity (our unpublished observation). Such aǹ incomplete' inhibition of HGF-induced cell scattering and MAP kinase activation may be due to the low eciency transfection of mutant MEK1 cDNA into MDCK cells. Indeed, in spite of all our eorts, the transfection eciency of cDNA into MDCK cells was Figure 5 Eect of AMPC-pretreatment on the HGF-, PMA-or EGF-induced activation of Raf-1 and PI3-kinase in MDCK and TMK1 cells. (A) MDCK cells were stimulated with 4 ng/ml of HGF for the indicated periods of time. Raf-1 assay was performed by incubating cell lysates (100 mg of protein) with anti-Raf-1 antibody followed by the kinase reaction. Radioactivity incorporated into GST-MEK1 K97A was quanti®ed with a Fujix Bioimaging analyser BAS 1500.
P incorporation into GST-MEK1
K97A is also shown by autoradiography (inset) (left panel). MDCK cells were preincubated with 0.1% Me 2 SO or 50 mM of AMPC for 30 min, followed by stimulation with 4 ng/ml of HGF or 30 ng/ml of PMA for 5 min. Raf-1 assay was performed as described above (central panel). TMK1 cells were preincubated with 0.1% Me 2 SO or 50 mM of AMPC for 30 min, followed by stimulation with 4 ng/ml of HGF or 10 ng/ml of EGF for 5 min. Raf-1 assay was performed as described above (right panel). Each value represents the mean+s.d. of duplicate determinations of a representative experiment. Similar results were obtained in 2 ± 4 independent experiments. (B) MDCK cells were preincubated with 0.1% Me 2 SO, 50 mM of AMPC or 0.5 mM of wortmannin for 30 min, followed by stimulation with 4 ng/ml of HGF for the indicated periods of time. PI3-kinase assay was performed by incubating cell lysates (500 mg of protein) with anti-phosphotyrosine antibody followed by the kinase reaction as described under Materials and methods. A PI3-kinase assay without cell lysates was used as a control (Buf). The position of phosphatidylinositol 3,4,5,-triphosphate (PI3, 4, 5 P 3 ) standard, a kind gift from Dr O Hazeki (University of Tokyo), is indicated (left panel). MDCK cells were preincubated with 0.1% Me 2 SO or 50 mM of AMPC for 30 min, followed by stimulation with 4 ng/ml of HGF for 3 min. HGF-induced tyrosine phosphorylation of PI3-kinase was analysed by incubating cell lysates (300 mg of protein) with anti-phosphotyrosine antibody (pTyr) or anti-PI3-kinase antibody which recognizes the p85 subunit of PI3-kinase (p85). The immunoprecipitates were resolved by SDS ± PAGE, electrophoretically transferred to an Immobilon-P membrane (Millipore), and probed with the anti-PI3-kinase antibody. Immunoreactive bands were then visualized by enhanced chemiluminescence (ECL) (Amersham) (right panel). The results shown are representative of three independent experiments below 10%. Nevertheless, the delayed motility response observed in the mutant MEK1-transfected cells is in support of the notion that the 41/43 kDa MAP kinase signaling pathway plays an important role in the HGFinduced cell scattering of MDCK cells. Very recently, when this manuscript was in the ®nal stage of preparation, stable transfection of MDCK-C7 cells with a constitutively active MEK1 mutant was reported to lead to increased activity of ERK2. These cells exhibited a spindle-shaped morphology which closely resembled that of MDCK cells induced to scatter by HGF-treatment (Schramek et al., 1997) . A requirement for ERKs MAP kinase activity in the migration of haptotaxis cells on a collagen substrate has also been demonstrated using the MEK inhibitor (PD98059) as well as by introducing a constitutively active MEK1 mutant into these cells (Klemke et al., 1997) .
It has been reported that PI3-kinase activity is required for the HGF-induced scattering of MDCK cells, based on results showing inhibition by wortmannin (Royal and Park, 1995) . Recently, however, wortmannin inhibition of MAP kinase (ERK) activation induced by several agents such as PDGF (Klippel et al., 1996) , platelet-activating factor (Ferby et al., 1996) , and interleukin-3 and granulocyte-macrophage colony-stimulating factor (Scheid and Duronio, 1996) has been reported. Thus, the inhibitory eect of wortmannin on HGF-induced cell scattering could be the result of indirect inhibition of ERK1/2 MAP kinases. Although wortmannin completely abolished HGF-induced activation of PI3-kinase under our experimental conditions ( Figure 5B ), it did not inhibit HGF-induced activation of 41/43 kDa MAP kinases signi®cantly, nor did it inhibit HGF-induced scattering of MDCK cells ( Figure 4A ). At present, we are unable to give a precise reason for the discrepancy between our results and those of other investigators with respect to wortmannin. In this context, activation of not only Ras but also Rac and some additional signaling molecule(s) has been reported to be required for HGF-induced scattering of MDCK cells (Ridley et al, 1995) . It might be that activation of the Ras/MAP kinase signaling pathway, together with the activation of Rac and PI3-kinase pathways, are required for the full induction of the scattering response following stimulation of MDCK cells with HGF; this possibility remains to be examined in future study.
A requirement for the activation of the 41/43 kDa MAP kinase signaling pathway for cell proliferation induced by the majority of, but not all (Chatani et al., 1995) mitogens has already been established (Nishida and Gotoh, 1993; Cobb and Goldsmith, 1995; Seger and Krebs, 1995) . In this respect, EGF treatment of MDCK cells also induced the activation of MEK, 41/ 43 kDa MAP kinases and p90 rsk with similar timecourse pro®les, but to lesser extents (60 ± 70%), as those observed in HGF-stimulated MDCK cells. This activation of the MAP kinase signaling pathway is most likely associated with the mitogenic action of EGF; EGF weakly induces the proliferation of MDCK cells but not their scattering, and AMPC inhibits the EGF-induced proliferation of these cells (data not shown). In mitogen-stimulated cells, a rapid translocation of the activated forms of 41/43 kDa MAP kinases from the cytoplasmic compartment to the nucleus is observed. In the nucleus, several transcription factors such as p62 TCF /Elk-1, c-Myc and c-Fos are phosphorylated by these MAP kinases. This leads to an elevated transactivation potential, which subsequently plays an important role in the induction of gene expression and DNA replication (Davis, 1993; Nishida and Gotoh, 1993; Cobb and Goldsmith, 1995; Seger and Krebs, 1995) . In contrast, such a rapid translocation of the activated 41/43 kDa MAP kinases has not clearly been observed in MDCK cells following stimulation with HGF; rather a large population of the activated MAP kinases remain in the cytoplasmic compartment (unpublished observation).
Induction of the motility response of MDCK and TMK1 cells following HGF-treatment involves cytoskeletal reorganization and perturbation of cell ± cell adhesion systems. In this context, changes in actin micro®lament organization (Dowrick et al., 1991) , and the reduction in the amount of insoluble E-cadherin and desmoplakins I/II at cell ± cell interfaces (Royal and Park, 1995) in HGF-treated MDCK cells have recently been reported. In addition, an increase in phosphorylation of E-cadherin-associated proteins, bcatenin and plakoglobin, has been observed in HGFtreated HT29, KMN7 and KMN74 cells, although phosphorylation was found to occur on tyrosine residue(s) (Shibamoto et al., 1994) . In HGF-stimulated MDCK cells, it may be that activated 41/43 kDa MAP kinases phosphorylate and modify the function of certain protein(s) involved in the regulation of cytoskeletal organization and/or cell ± cell adhesion. Further investigation will be required to identify proteins whose phosphorylation by activated MAP kinases is essential for the induction of motility response following HGF treatment of MDCK/TMK1 cells. This would provide a solid foundation for understanding how the 41/43 kDa MAP kinases are involved in the signaling pathway of HGF to induce cell scattering.
Materials and methods
Materials
Human recombinant factor HGF was puri®ed from the culture medium of CHO cells transfected with a plasmid containing human HGF cDNA as described (Nakamura et al., 1989) . EGF puri®ed from mouse submaxillary glands was purchased from Toyobo Co (Osaka, Japan), and PMA was from Sigma Chemical Co. A polyclonal anti-MAP kinase antibody was raised against residues 299 ± 321 (RIEVEQALAHPYLEQYYDPSDEP) of 41 kDa MAP kinase (ERK2) and was shown to recognize both the 43 kDa and 41 kDa MAP kinases (Chatani et al., 1992 (Chatani et al., , 1995 . The polyclonal anti-Raf-1 antibody (C-12) was obtained from Santa Cruz Biotechnology, Inc, the monoclonal anti-MEK1 antibody was from Transduction Laboratories, and the polyclonal anti-p90 rsk antibody (rsk-CT), p90 rsk substrate peptide (S6 peptide; RRRLSSLRA), monoclonal anti-phosphotyrosine antibody (4G10), polyclonal anti-PI3-kinase antibody and GST-MEK1 K97A were from Upstate Biotechnology, Inc. The cDNA for ERK2 K52R (Rossomando et al., 1992 ) (a kind gift from Dr MJ Weber, University of Virginia Health Sciences Center) was expressed in Escherichia coli as a glutathione S-transferase (GST)-fusion protein, and the protein was subsequently puri®ed by anity chromatography using GSH-Sepharose (Pharmacia Biotech Inc) (Smith et al., 1990) . 2-(2-amino-3-methoxyphenyl) chromone (AMPC), which is identical to the published compound PD98059 (Dudley et al., 1995) , was synthesized by the Baker ± Venkataraman rearrangement of o-acetylphenyl 3-methoxy-2-nitrobenzoate followed by cyclization and reduction in 28% yield. The compound was fully characterized by 1 H-NMR, 13 C-NMR, infrared and mass spectroscopy. Wortmannin was purchased from Sigma Chemical Co, rapamycin was from Biomol Research Labs, Inc, and SB203580 (Cuenda et al., 1995) was from Calbiochem. Other chemicals and reagents were of the purest grade available.
Cell culture
MDCK cells were obtained through the Japanese Cancer Research Resources Bank, and TMK1 cells were kindly provided by Dr E Tahara (Hiroshima University). Cells were cultured in Dulbecco's modi®ed Eagle's medium supplemented with 10% fetal calf serum.
Cell lysis and immunoprecipitation
MDCK and TMK1 cells treated with HGF, PMA, or EGF were washed twice with ice-cold phosphate-buered saline, scraped o plates into an appropriate cell lysis buer, and then¯ash-frozen in liquid nitrogen. The cell lysis buer used were as follows: a hypotonic cell lysis buer (25 mM Tris-HCl, pH 7.4, 25 mM NaCl, 1 mM sodium orthovanadate, 10 mM NaF, 10 mM sodium pyrophosphate, 25 mM b-glycerophosphate, 25 mM, p-nitrophenylphosphate, 20 nM okadaic acid, 0.2 mM sodium molybdate, 0.5 mM EGTA, 1 mM phenylmethylsulfonyl¯uoride, 10 mg/ml leupeptin, and 1% aprotinin) for the analysis of 41/ 43 kDa MAP kinases, MEK and p90 rsk ; a SDS-containing RIPA buer (20 mM Tris-HCl, pH 8.0, 137 mM NaCl, 10% glycerol, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate, 1 mM sodium orthovanadate, 2 mM EDTA, 1 mM phenylmethylsulfonyl¯uoride, 10 mg/ml leupeptin, and 1% aprotinin) for the analysis of Raf-1. After three freeze-thaw cycles, cells were lysed by passing them through a 25-gauge needle followed by sonication for 30 s. Lysates were cleared by centrifugation at 12 000 g for 30 min, and protein concentrations were determined using the BCA protein assay reagent (Pierce). Cell lysates (10 ± 100 mg of protein) were then immunoprecipitated by incubating for 3 h at 48C with each of respective antibodies preadsorbed to protein-A Sepharose (Pharmacia Biotech Inc). For the immunoprecipitation of 41/ 43 kDa MAP kinases, cell lysates were pretreated with 0.1% SDS for 20 min at 48C, diluted 1 : 10 in cell lysis buer, and then the antibody was added (Chatani et al., 1992 (Chatani et al., , 1995 . The immunoprecipitates were washed three times with each of the respective cell lysis buers. For protein kinase assays, immunoprecipitates were then washed twice with the kinase buer A (50 mM Tris-HCl, pH 8.0, 25 mM MgCl 2 , 0.5 mM EGTA, 1 mM dithiothreitol, and 0.1 mM Na 3 VO 4 ) for 41/43 kDa MAP kinases or MEK, the kinase buer B (30 mM Tris-HCl, pH 7.4, 7 mM MnCl 2 , 5 mM MgCl 2 and 1 mM dithiothreitol) for Raf-1, or the kinase buer C (20 mM Tris-HCl, pH 7.2, 10 mM MgCl 2 and 1 mM dithiothreitol) for p90 rsk .
Protein kinase assays
The activities of 41/43 kDa MAP kinases, MEK, Raf-1, and p90 rsk were measured in an immune complex kinase assay. Brie¯y, each immunoprecipitate prepared as described above was incubated for 30 ± 60 min at 308C with 20 mM ATP and 2 ± 10 mCi of [g-32 P]ATP (Amersham) in 30 ml of each of the respective kinase buers: 41/43 kDa MAP kinase assays were performed with 15 mg of myelin basic protein (MBP) (Sigma) as substrate, MEK assays were performed using 2 mg of GST-ERK2 K52R , p90 rsk assays were performed using 6 mg of S6 peptide, and Raf-1 assays were performed using 2 mg of GST-MEK K97A . Kinase reactions were terminated by adding (i) 10 ml of 46SDS sample buer, and the incorporation of 32 P into substrate proteins was examined by SDS-polyacrylamide gel electrophoresis (PAGE) followed by autoradiography using a Fujix Bioimaging analyser BAS 1500 (Fuji Photo Film Co, Tokyo, Japan) (for assays of 41/43 kDa MAP kinases, MEK and Raf-1), or (ii) 10 ml of 0.6% HCl containing 1 mM ATP and 1% bovine serum albumin, and then an aliquot (30 ml) was spotted onto phosphocellulose papers (P81, Whatman), washed ®ve times in 180 mM phosphoric acid, and radioactivity incorporated into MBP or the substrate peptide was determined by liquid scintillation spectrometry (for assays of 41/43 kDa MAP kinases and p90 rsk ). Our anti-MAP kinase antibody recognized both the 41 kDa and 43 kDa MAP kinases, and thus all the MBP phosphorylation activity of each of the anti-MAP kinase antibody immunoprecipitates shown in this report is the sum of both 41 kDa and 43 kDa MAP kinase activity. The synchronous activation of both of the 41 kDa and 43 kDa MAP kinases in HGF-, PMA-, and EGF-stimulated cells was con®rmed by doing the kinase detection assay within a polyacrylamide gel containing MBP (data not shown) (Chatani et al., 1992) .
PI3-kinase assay
PI3-kinase activity was determined as described (Okada et al., 1996) with slight modi®cations. Brie¯y, MDCK cells pretreated with or without AMPC/wortmannin for 30 min and stimulated with HGF for varying periods of time were lysed in the hypotonic cell lysis buer which was lack of pnitrophenylphosphate and supplemented with 1% NP-40. Cell lysates (500 mg of protein) were incubated ®rst with an anti-phosphotyrosine antibody (2 mg/sample) for 2 h and then with protein G-Sepharose (Pharmacia Biotech Inc) for 1 h. After washing, PI3-kinase activity of the immunoprecipitate was determined in 100 ml of an assay mixture consisting of 40 mM Tris-HCl (pH 7.4), 0.5 mM EGTA, 5 mM MgCl 2 , 0.2 mM phosphatidylinositol 4,5-diphosphate (Sigma), 0.2 mM phosphatidylserine (Avanti Polar-Lipids, Inc), and 0.1 mM (5 mCi) [g-32 P]ATP. The reaction was carried out at 308C for 15 min and then stopped by the addition of 20 ml of 6% HClO 4 and 450 ml of chloroform/ methanol (1 : 2, v/v). After vigorous stirring, 150 ml of CHCl 3 and 150 ml of 1% HClO 4 were added to the mixture to separate the organic phase, which was then evaporated to dryness. The extract was dissolved in 20 ml of chloroform/methanol (95 : 5) and spotted on a silica gel plate (Merck, Silica Gel 60) that had been previously impregnated with potassium oxalate by developing with a solvent system comprising 1.2% potassium oxalate in methanol/ water (2 : 3) and activated by heating at 1108C for 20 min. The plate was developed in CHCl 3 /methanol/acetone/acetic acid/H 2 O (7 : 5 : 2 : 2 : 2), dried, and the radioactivity in individual spots was visualized with a Fujix Bioimaging analyzer BAS 1500.
